EMCARD 5 - Dr Precision

EMCARD 5 TAB is a high-quality formulation containing Bisoprolol Fumarate 5 mg, a beta-1 selective adrenergic receptor blocker known for its efficacy in treating cardiovascular conditions such as high blood pressure, ischemic heart disease, and chronic heart failure. Its cardioselective action helps control blood pressure and reduce myocardial oxygen demand, offering protection against future cardiovascular events while minimizing effects on the lungs, unlike non-selective beta-blockers.

Bisoprolol, the active ingredient in EMCARD 5, selectively blocks beta-1 receptors in the heart, leading to a reduction in heart rate, cardiac output, and blood pressure. Its once-daily dosing and favorable side effect profile make it suitable for long-term therapy in patients with cardiovascular risks. Clinical evidence supports its use in reducing hospitalizations and mortality in heart failure patients, particularly those with reduced ejection fraction.

BluepillExpress manufactures EMCARD 5 TAB in WHO-GMP-certified facilities, ensuring international quality, consistency, and regulatory compliance. The product is customizable for private label branding, bulk purchasing, and country-specific registration documentation.

✅ Therapeutic Indications

Hypertension (High Blood Pressure)

Chronic Stable Angina

Congestive Heart Failure (CHF)

Post-Myocardial Infarction Care

Cardiac Arrhythmias (Off-label use)

✅ Mechanism of Action

Bisoprolol binds selectively to beta-1 adrenergic receptors in cardiac tissue. By blocking these receptors, it inhibits the sympathetic nervous system's effect on the heart, reducing:

Heart rate

Cardiac output

Myocardial oxygen demand

This results in lowered blood pressure, improved myocardial efficiency, and reduced risk of angina or heart failure progression.

✅ Pharmacological Benefits

High cardioselectivity – safer for patients with mild asthma or COPD

Improves cardiac function in CHF patients

Once-daily dosing improves patient compliance

Minimal metabolic effects – suitable for diabetic and elderly patients

Evidence-based survival benefit in heart failure